Purity:SDS-PAGE

Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (durvalumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

Purity:SEC-HPLC

The purity of Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (durvalumab) is 100%, determined by SEC-HPLC.

Research in vivo

Durvalumab inhibited the tumor growth of A375 on NOD.SCID mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 61.2% at 5 mpk at D22.

-25~-15℃保存，有效期1年。